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Scedosporium proliﬁcans is an emerging fungal pathogen
that can cause signiﬁcant morbidity, and even mortality,
in both immunocompromised and immunocompetent
patients. Approximately 10% of patients affected by this
rare fungal pathogen present with septic osteomyelitis or
arthritis. Overall, the rate of mortality is close to 50%, and
several patients with orthopedic infections have required
amputations.1
Our patient is a 59-year-old woman, with a history of
rheumatoid arthritis requiring immunosuppressants, who
presented with a 5-month history of right wrist pain and
swelling. She described an oscillating course of swelling,
erythema, and pain involving the dorsal aspect of her wrist
that did not show sustained response to antibiotics or a
radiocarpal joint steroid injection given by other providers.
On initial examination, she was afebrile with dorsal wrist
swelling. There was no erythema, but wrist mobility was
limited. She had tenderness throughout the wrist, but no
ﬂuctuance or drainage. All initial laboratory work was
normal. Right wrist X-ray showed severe osteopenia with
some mild evidence of cortical erosion.
Despite the normal laboratory values, her presenting
ﬁndings of swelling, radiographic erosions, and immunocom-
promised state prompted concern for atypical septic arthritis.
The patient subsequently underwent wrist exploration
for tissue and culture harvest. In addition to extensive
wrist synovectomy, the proximal pole of the scaphoid, lunate,
triquetrum, capitate, hamate, and metacarpal bases all
showed evidence of necrosis that required debridement.
One week later, her ﬂuid aspirate and bone cultures unex-
pectedly grew an unidentiﬁed fungal species, and she was
taken back to the operating room for further debridement
and placement of a voriconazole-impregnated cement
spacer.
The culture grew pan-resistant Scedosporium proliﬁcans,
and based on recommendations from Rheumatology and
Infectious Disease, the patient was started on a 6-week course
of intravenous micafungin, and immunosuppressive medi-
cations were stopped. She returned to the operating room for
debridement and serial treatments with polyhexamethylene
biguanide (PHMB) irrigation until intraoperative tissue cul-
tures showed no growth. PHMB is an antiseptic medication
that has been described as a local adjunct to the treatment of
resistant fungal infections.2–4 After successful eradication of
her infection, she underwent wrist reconstruction and fusion
with a double-barrel free ﬁbula osteocutaneous ﬂap. She is
now 18 months out from her reconstruction, has healed
uneventfully, and has a functional, painless upper extremity
(►Fig. 1).
Fig. 1 Radiograph 5months after reconstructionwith signs of bony healing.
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Due to the rare nature of this infection, all the information
and guidance for treatment comes from case reports or case
series. The most comprehensive analysis of cases from the
literature compiles data on 162 patients with Scedosporium
proliﬁcans infection.1 The overall mortality for the 162 pa-
tients in the study was 46.9%; however, the vast majority of
fatal infections occurred in immunocompromised patients
with disseminated disease, and only 10% of patients in this
series had osteomyelitis or septic arthritis. All, except one, of
the patients with orthopedic infections suffered some form of
previous trauma. None of these patients died, but two
required amputations for cure.
This case demonstrates the high potential for morbidity
associated with Scedosporium proliﬁcans septic arthritis
and osteomyelitis of the wrist. We describe a successful
eradication of this challenging pathogen and a creative
solution for reconstruction with a double-barrel free ﬁbula
osteocutaneous ﬂap. Hand surgeons should consider this
pathogen when evaluating patients for atypical infections,
especially if the patient is immunocompromised. Evidence-
based treatment guidelines are not currently available,
but treatment should generally include adequate debride-
ment, systemic antifungal therapy, and potentially PHMB
irrigation.
Note
All identifying details werewithheld to protect the privacy
of our patient. Informed consent was obtained for photo-
graphs and their use for publication.
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